The drug sensitivity analysis revealed that CASP3, CASP9, GSDMB, GSDMD, and NLRC4 were associated with multiple anticancer drug efficacy, which suggested that pyroptosis genes may be involved in pan-cancer signaling pathways and influence anticancer drug efficacy in the cancer therapeutic response portal database (Figure 8K). This evidence concerns the gene NLRC4 and cancer.